The high prices of prescription drugs have sparked criticism from various figures, including Senator Jeff Merkley and Senator Elizabeth Warren, who advocate for fair drug pricing. Calls for transparency in drug pricing have been echoed by Representative Katie Porter, highlighting the need for Americans to know the cost of their medications. The pharmaceutical industry faces scrutiny for deceptive practices, such as omitting drug prices in advertisements, prompting legislative action to increase transparency.
Solid, short take on GLP-1 budget impact: https://t.co/FURTMxFNBh by @TreedinDC @axios But in big market like this, shouldn’t pts switching out of pvt plans ~ pts switching in? (Except when pts transition to Medicare, obvi. But that’s not the argument that’s being made here.) https://t.co/jGBkH576vR
🚨 Russell 2000 Rebalancing - April 30th $XBI
$XBI $DCPH buyout Reverse jinxing started to work! https://t.co/8QPWCyfiVs
IRA’s 9y pill penalty woke up many in biotech to consequences of public’s hatred of pharma, blamed for high OOP costs. Many now seek roadmap for fixing problem at its root. Countless tactics… TBD. The strategy is here: @nplb_org @iambiotech @phrma https://t.co/JnzCgidYXO
IRA’s 9y pill penalty woke up many in biotech to consequences of public’s hatred of pharma, blamed for high OOP costs. Many now a roadmap for fixing problem at its root. Countless tactics… TBD… but the strategy is here. @nplb_org @iambio @phrma https://t.co/JnzCgidYXO
Big Pharma's drug ads have a lot of info—benefits, dosage, and potential side effects—but not the price. When I called out this deceptive tactic, an industry lobbyist doubled down! @RepNikema and I introduced the Plain Prescription Prices Act to get Americans transparency. https://t.co/dto63PWrLF
$XBI @BiotechCH diversifying the discussion yesterday to include topics of general business import, including capital gains tax rates and possible taxation of unrealized gains (the less said about this abomination, the better), and also: FTC rule banning non-competes…… https://t.co/j1RSwhFjI8
$XBI @BiotechCH diversifying the discussion yesterday to include topics of general business importance, including capital gains tax rates and possible taxation of unrealized gains (the less said about this abomination, the better), and also: FTC rule banning non-competes…… https://t.co/f8zOC3kJqk
Americans pay more for life-saving drugs than people living anywhere in the world even though our tax dollars are used to research & develop many of those drugs. @POTUS proposed new guidance so Americans can get a fair price for drugs they help develop. It’s time to finalize it.
Sky high prescription drug prices are Big Pharma’s corporate greed on full display. No one should have to make the impossible choice between filling a prescription and putting food on the table. That’s why I’m fighting to pass my End Price Gouging for Medications Act!
"Hey, Insurance Companies and Pharmacies — Stop Messing Around with the Price of Cheap Generic Drugs." So says @PaulSaxMD in the latest HIV and ID Observations. https://t.co/kxq3oNVjR0 https://t.co/OyLb4QBVAw